All News

Placing the opioid overdose antidote naloxone behind pharmacy counters across the United States could provide a catalyst for pharmacists to play a central role as facilitators for drug addiction treatment.

Chikungunya was rarely seen in US travelers before 2006, but the virus has grown more prevalent. Now, almost all states have seen at least one case of the disease in US travelers this year.

Diabetes has a tremendous global impact, but developing nations often struggle to help patients deal with their disease.

Trial data shows positive results across a range of difficult-to-treat patients with MM.

Research may lead to gel that prevents transmission of HIV, hepatitis C and the Ebola virus.

HIMSS is working to determine the readiness of providers to participate in the types of value-based payment models that CMS is moving toward.

Researchers examine impact of probiotics on inflammatory bowel disease.

XSTAT 30 is typically used to control life-threatening bleeding in military settings.

Early preventive action is key for patients in terms of heart health, and it allows pharmacists to play an important role in disease management.

All MTM services may be billed for, but the question remains: which insurance companies will reimburse them?

Pharmacists have more work to do to educate patients on the importance and efficacy of flu vaccination, a new poll reveals.

A pharmacy must pay $60,000 in a settlement resolving allegations that it violated the Controlled Substances Act and the Combat Methamphetamine Epidemic Act of 2005.

A Massachusetts pharmacist is speaking out about prescription drug abuse and heroin addiction in a new HBO documentary available later this month.

Letters of recommendation are by far the most-valued component of the residency application packet.

The FDA is now allowing civilians to access XSTAT 30 wound dressing, an expandable, multi-sponge product typically used to control life-threatening bleeding in military settings.

An HCV vaccine, while elusive, offers the best hope to eradicate the virus.

Top news of the week in cancer drug development.

Eating before bed can have a significant impact on the development of nonalcoholic fatty liver disease.

Researchers consider the ramifications of using organs from infected patients to save lives.

Liver damage caused by hepatitis C may eventually be overcome through stem cell therapy.

Researchers target effect of various medical conditions on platelet function.

New treatment option for patients who no longer respond to Xalkori.

Enhanced screening and treatment in high-risk populations could eliminate virus.

Top stories of the week on Specialty Pharmacy Times.

Researchers target how cancer cells avoid treatment.

Needle mechanism that delivers insulin fails to deploy or is delayed.

Clean needle programs have reduced HIV incidence among injection drug abusers by 80% from 1990 to 2006.

Shopping around carefully for plans will be important for Medicare Part D enrollees.

Through a voluntary field safety notification, Insulet Corporation is notifying consumers and health care professionals about a slight increase in reports in which the OmniPod's needle mechanism to deliver insulin fails to deploy or is delayed.

The FDA has approved Otonomy's ciprofloxacin otic suspension for the treatment of bilateral otitis media with effusion in pediatric patients who are undergoing tympanostomy tube placement.